-

Haug Partners Congratulates Ralph Labaton on Elevation to Partner

NEW YORK--(BUSINESS WIRE)--Haug Partners LLP is excited to announce the elevation of Ralph Labaton to Partner as of January 1, 2024..

Ralph Labaton’s work focuses on antitrust litigation and other complex litigation matters. He has significant experience litigating class actions across multiple industries, including reverse payment and “pay-for-delay” pharmaceutical actions.

Mr. Labaton also devotes his time to community efforts, including serving as a Member of the Young Professionals Committee of Friends of Jerusalem College of Technology. Mr. Labaton is also serving as an editor of the ABA Antitrust Law Section’s IP and Antitrust Handbook publication.

Mr. Labaton earned his J.D. from Cornell Law School (2016) with a concentration in Business Law & Regulation, where he was the Vice President of the Mock Trial Board and a Co-Founder of The Louis D. Brandeis Center for Human Rights Under Law. Mr. Labaton also earned the CALI Award for Excellence for his efforts in the Securities Law Clinic, where he represented investors in FINRA arbitration proceedings. Mr. Labaton earned his B.B.A., cum laude, from Baruch College, Zicklin School of Business (2013).

Ed Haug, firm Chairman, noted that, “We could not be prouder of our own home trained associate Ralph Labaton. He has demonstrated superior legal skills and work ethic that has greatly benefitted our clients, our partnership and the legal community. We look forward to a great future at the firm.”

Haug Partners LLP is a national law firm that provides integrated, multidisciplinary legal services in the areas of Intellectual Property, FDA law, and antitrust and commercial transactions. The firm has offices in New York, Washington, D.C., and West Palm Beach.

Haug Partners LLP


Release Versions

Social Media Profiles
More News From Haug Partners LLP

Jennifer Patterson joins Haug Partners LLP’s Antitrust group

NEW YORK--(BUSINESS WIRE)--Haug Partners LLP is excited to welcome Jennifer Patterson as a partner in its New York office. Ms. Patterson has more than 25 years of experience handling antitrust litigation and other complex commercial disputes across a wide range of industries including pharmaceuticals, rail freight transportation, publishing, auto parts, aircraft parts, biometric identification, poultry breeding, food additives, pesticides, optical film, flat glass manufacturing, and accounting...

Haug Partners Successfully Defends Takeda’s Vyvanse® Patents At Trial Against Generic Challenge

NEW YORK--(BUSINESS WIRE)--On December 27, 2022, Haug Partners LLP and Gibbons PC obtained a key victory as to all counts for its client, plaintiffs Takeda Pharmaceutical Co. Ltd. and Takeda Pharmaceuticals U.S.A., Inc., defeating a generic challenge by Norwich Pharmaceuticals Inc. to Takeda’s Orange Book-listed patents for Takeda’s multibillion dollar Vyvanse® product. In a 107-page Opinion, Judge Stanley R. Chesler (D.N.J.) found that Takeda prevailed on all fourteen asserted claims in the ma...

Haug Partners LLP Welcomes New Partner, Wan Chieh (Jenny) Lee

NEW YORK--(BUSINESS WIRE)--Haug Partners LLP today announced that Wan Chieh (Jenny) Lee has joined the firm as a partner in its New York City office....
Back to Newsroom